Darren Smyth is a partner, UK and European patent attorney, design attorney, and UPC representative at EIP

27 June 2024FeaturesEuropeDarren Smyth

Unified Patent Court: The cases, the numbers and what the future holds

In its first year, uptake of cases at the Unified Patent Court has surpassed most expectations. Darren Smyth of EIP delves into the facts and figures behind the headlines, with some surprising results.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Life sciences cases at the UPC will surely rise, but is the court prepared?

18 June 2024 Signs show that an uptick of life sciences cases at the Unified Patent Court is likely, but does the court have capacity? Anna Leathley, Richard Newell & Sarah Mitchell of Carpmaels & Ransford explore.

article

Looking back at the UPC’s ‘successful’ first year

4 June 2024 Court seen as “exceeding expectations” | Experts urge caution, emphasising that confident and reliable court judgments are needed | High-stakes patent litigation, especially in pharmaceuticals, remains predominantly within national courts.

More on this story

Life sciences cases at the UPC will surely rise, but is the court prepared?

18 June 2024 Signs show that an uptick of life sciences cases at the Unified Patent Court is likely, but does the court have capacity? Anna Leathley, Richard Newell & Sarah Mitchell of Carpmaels & Ransford explore.

article

Looking back at the UPC’s ‘successful’ first year

4 June 2024 Court seen as “exceeding expectations” | Experts urge caution, emphasising that confident and reliable court judgments are needed | High-stakes patent litigation, especially in pharmaceuticals, remains predominantly within national courts.

More on this story

Life sciences cases at the UPC will surely rise, but is the court prepared?

18 June 2024 Signs show that an uptick of life sciences cases at the Unified Patent Court is likely, but does the court have capacity? Anna Leathley, Richard Newell & Sarah Mitchell of Carpmaels & Ransford explore.

article

Looking back at the UPC’s ‘successful’ first year

4 June 2024 Court seen as “exceeding expectations” | Experts urge caution, emphasising that confident and reliable court judgments are needed | High-stakes patent litigation, especially in pharmaceuticals, remains predominantly within national courts.

More features

Teva faces $500m fine for antitrust breaches over MS drug

UK Budget: A missed opportunity?

Cooley adds ex-Gowling partner

How post-filing data rescued Novo Nordisk’s Ozempic patent in China

Jones Day hires pharma and high-tech patent litigator to London office

Powell Gilbert co-founder moves to US firm

GSK: ‘Whoever moves first has UPC advantage’

Pfizer and BioNTech win UK COVID-19 dispute